| | | | | |
AGIO Agios Pharmaceuticals, Inc. | $28.7800 | +3.97% | $1.74B | $648.16K | |
SGRY Surgery Partners, Inc. Common Stock | $13.6750 | +1.22% | $1.74B | $1.54M | |
GAB The Gabelli Equity Trust Inc. | $5.6000 | -0.18% | $1.74B | $1.27M | |
HURN Huron Consulting Group Inc. | $107.28 | +2.36% | $1.74B | $133.31K | |
ENVX Enovix Corporation Common Stock | $8.3600 | +1.58% | $1.74B | $7.25M | |
PAYO Payoneer Global Inc. Common Stock | $5.1300 | +0.79% | $1.74B | $6.51M | |
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | $14.9300 | +0.13% | $1.73B | $174.04K | |
STGW Stagwell Inc. Class A Common Stock | $6.6900 | +1.52% | $1.73B | $964.68K | |
CASH Pathward Financial, Inc. Common Stock | $79.0350 | +1.67% | $1.73B | $296.81K | |
SNDX Syndax Pharmaceuticals, Inc. | $18.0200 | -1.74% | $1.73B | $7.79M | |
STRA Strategic Education, Inc. Common Stock | $80.4500 | +1.77% | $1.73B | $223.18K | |
CAPR Capricor Therapeutics Inc | $27.9200 | +1.01% | $1.73B | $584.20K | |
AAPG Ascentage Pharma Group International American Depository Shares | $17.8250 | -0.25% | $1.73B | $4.88K | |
SLS SELLAS Life Sciences Group, Inc. Common Stock | $9.0400 | +10.38% | $1.73B | $8.36M | |
PLSE Pulse Biosciences, Inc Common Stock (DE) | $26.9250 | +7.74% | $1.73B | $640.65K | |
